HIV vaccine hunt: four cocktails face off in human trial
NCT ID NCT02038842
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study tested four different HIV vaccine combinations in 92 healthy volunteers at low risk of HIV. The goal was to see which combination is safest and best at triggering the body's immune system to fight HIV. The vaccines use a 'prime-boost' approach, where the first shot primes the immune system and a later shot boosts it. This trial helps researchers pick the most promising vaccine strategy for future larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Service d'Immunologie Clinique 51, avenue du Marechal de Lattre de Tassigny
Créteil, 94010, France
Conditions
Explore the condition pages connected to this study.